Cargando…
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release
Autores principales: | Martinotti, Giovanni, Barlati, Stefano, Prestia, Davide, Palumbo, Claudia, Giordani, Matteo, Cuomo, Alessandro, Miuli, Andrea, Paladini, Carlo, Amore, Mario, Bondi, Emi, Vita, Antonio, Fagiolini, Andrea, Di Giannantonio, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441014/ https://www.ncbi.nlm.nih.gov/pubmed/32821983 http://dx.doi.org/10.1007/s00213-020-05644-3 |
Ejemplares similares
-
Delirium in COVID-19 patients: a multicentric observational study in Italy
por: Martinotti, Giovanni, et al.
Publicado: (2021) -
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
por: Miuli, Andrea, et al.
Publicado: (2020) -
Treatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review
por: Amore, Mario, et al.
Publicado: (2021) -
Psychomotor Agitation Following Treatment with Hydroxychloroquine
por: Manzo, Ciro, et al.
Publicado: (2017) -
The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review
por: Pompili, Maurizio, et al.
Publicado: (2021)